Liver Surface Nodularity Score Allows Prediction of Cirrhosis Decompensation and Death

Andrew D Smith1, Kevin A Zand1, Edward Florez1

  • 1From the Departments of Radiology (A.D.S., K.A.Z., E.F., R.S., D.S., F.S., M.R.) and Data Science (M.G., S.T.L.), University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216; and ImageIQ, Cleveland, Ohio (J.B., A.V.).

Radiology
|November 5, 2016
PubMed

Insights

The liver surface nodularity (LSN) score, measured from CT scans, can predict cirrhosis decompensation and death. This quantitative biomarker offers valuable prognostic information for patients with liver disease.

Area of Science:

  • Radiology
  • Hepatology
  • Medical Prognostics

Background:

  • Cirrhosis significantly increases the risk of decompensation and mortality.
  • Current prognostic models may not fully capture individual patient risk.
  • Non-invasive biomarkers are needed for better risk stratification in cirrhosis.

Purpose of the Study:

  • To evaluate the liver surface nodularity (LSN) score as a predictor of hepatic decompensation and death in patients with cirrhosis.
  • To assess the independent predictive value of LSN score beyond the Model for End-Stage Liver Disease (MELD) score.

Main Methods:

  • Retrospective study of 830 adult patients with cirrhosis and recent MELD scores.
  • LSN score quantified from routine computed tomographic (CT) images using specialized software.
  • Competing risk regression analysis to assess the association of LSN score with decompensation and survival.

Main Results:

  • LSN score independently predicted hepatic decompensation (HR, 1.38) and death (HR, 1.22) in patients with cirrhosis.
  • Median time to decompensation varied significantly across LSN risk groups (low, intermediate, high).
  • LSN score and MELD score were both independent predictors of mortality.

Conclusions:

  • The liver surface nodularity (LSN) score, derived from routine CT scans, is a valuable tool for predicting cirrhosis decompensation.
  • LSN score provides independent prognostic information for patient survival in cirrhosis.
  • Combining LSN and MELD scores can enhance risk prediction for liver-related events.

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
972
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
247
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
709
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K